Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use

Show full item record



Permalink

http://hdl.handle.net/10138/312902

Citation

Chd Exome Consortium , Consortium Genetics Smoking , EPIC-CVD Consortium , Understanding Soc Sci Grp , Brazel , D M , Jiang , Y , Hughey , J M , Loukola , A , Qaiser , B , Kaprio , J , Kontto , J , Perola , M & Dunning , A M 2019 , ' Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use ' , Biological Psychiatry , vol. 85 , no. 11 , pp. 946-955 . https://doi.org/10.1016/j.biopsych.2018.11.024

Title: Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use
Author: Chd Exome Consortium; Consortium Genetics Smoking; EPIC-CVD Consortium; Understanding Soc Sci Grp; Brazel, David M.; Jiang, Yu; Hughey, Jordan M.; Loukola, Anu; Qaiser, Beenish; Kaprio, Jaakko; Kontto, Jukka; Perola, Markus; Dunning, Alison M.
Contributor: University of Helsinki, HUSLAB
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
Date: 2019-06-01
Language: eng
Number of pages: 10
Belongs to series: Biological Psychiatry
ISSN: 0006-3223
URI: http://hdl.handle.net/10138/312902
Abstract: BACKGROUND: Smoking and alcohol use have been associated with common genetic variants in multiple loci. Rare variants within these loci hold promise in the identification of biological mechanisms in substance use. Exome arrays and genotype imputation can now efficiently genotype rare nonsynonymous and loss of function variants. Such variants are expected to have deleterious functional consequences and to contribute to disease risk. METHODS: We analyzed similar to 250,000 rare variants from 16 independent studies genotyped with exome arrays and augmented this dataset with imputed data from the UK Biobank. Associations were tested for five phenotypes: cigarettes per day, pack-years, smoking initiation, age of smoking initiation, and alcoholic drinks per week. We conducted stratified heritability analyses, single-variant tests, and gene-based burden tests of nonsynonymous/loss-of-function coding variants. We performed a novel fine-mapping analysis to winnow the number of putative causal variants within associated loci. RESULTS: Meta-analytic sample sizes ranged from 152,348 to 433,216, depending on the phenotype. Rare coding variation explained 1.1% to 2.2% of phenotypic variance, reflecting 11% to 18% of the total single nucleotide polymorphism heritability of these phenotypes. We identified 171 genome-wide associated loci across all phenotypes. Fine mapping identified putative causal variants with double base-pair resolution at 24 of these loci, and between three and 10 variants for 65 loci. Twenty loci contained rare coding variants in the 95% credible intervals. CONCLUSIONS: Rare coding variation significantly contributes to the heritability of smoking and alcohol use. Fine-mapping genome-wide association study loci identifies specific variants contributing to the biological etiology of substance use behavior.
Subject: Alcohol
Behavioral genetics
GWAS
Heritability
Nicotine
Tobacco
SEQUENCE VARIANTS
MISSENSE VARIANTS
LOW-FREQUENCY
NICOTINE
ASSOCIATION
DEPENDENCE
COMMON
ADH1B
RISK
HERITABILITY
3112 Neurosciences
3124 Neurology and psychiatry
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Exome_Chip_Meta ... moking_and_Alcohol_Use.pdf 193.3Kb PDF View/Open
1_s2.0_S0006322318320560_main.pdf 125.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record